Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
Cancers · 28.03.2024 · 16 (7) · 1313
DOI: 10.3390/cancers16071313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.03.2024. Verfasst von Amogh Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Healthy Longevity and NUS Centre for Cancer Research Translation Research Program, Yong Loo Lin School of Medicine, Nationa…. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, National Medical Research Council.
Abstract (Originalsprache)
Metabolic plasticity is recognised as a hallmark of cancer cells, enabling adaptation to microenvironmental changes throughout tumour progression. A dysregulated lipid metabolism plays a pivotal role in promoting oncogenesis. Oncogenic signalling pathways, such as PI3K/AKT/mTOR, JAK/STAT, Hippo, and NF-kB, intersect with the lipid metabolism to drive tumour progression. Furthermore, altered lipid signalling in the tumour microenvironment contributes to immune dysfunction, exacerbating oncogenesis. This review examines the role of lipid metabolism in tumour initiation, invasion, metastasis, and cancer stem cell maintenance. We highlight cybernetic networks in lipid metabolism to uncover avenues for cancer diagnostics, prognostics, and therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, Healthy Longevity and NUS Centre for Cancer Research Translation Research Program, Yong Loo Lin School of Medicine, National University of Singapore (NUS), 2 Medical Drive, MD9, Singapore 11759…
ORCID-Profile: Reshma Taneja
Förderung
- Ministry of Education
- National Medical Research Council
Zitieren
APA
Gupta, A., Das, D., & Taneja, R. (2024). Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors. Cancers, 16(7), 1313. https://doi.org/10.3390/cancers16071313
Vancouver
Gupta A, Das D, Taneja R. Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors. Cancers. 2024;16(7):1313. doi:10.3390/cancers16071313
BibTeX
@article{Gupta2024,
author = {Gupta, Amogh and Das, Dipanwita and Taneja, Reshma},
title = {Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors},
journal = {Cancers},
year = {2024},
volume = {16},
number = {7},
pages = {1313},
doi = {10.3390/cancers16071313}
}
EUVIMED